M RE4 (Ropinirole Hydrochloride Extended-Release 4 mg)
Pill with imprint M RE4 is Brown, Round and has been identified as Ropinirole Hydrochloride Extended-Release 4 mg. It is supplied by Mylan Pharmaceuticals Inc..
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M RE4
Ropinirole Hydrochloride Extended-Release
- Imprint:
- M RE4
- Strength:
- 4 mg
- Color:
- Brown
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-4091
More about ropinirole
- Ropinirole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 237 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
Other brands: Requip, Requip XL
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
